Life ScienceCompany
Hemax Genome Ownership
Who owns Hemax Genome?
Hemax Genome is owned by Emerillon Therapeutics. It was acquired on October 7, 2005.
Hemax Genome Business Overview
Where is Hemax Genome headquartered?
Hemax Genome is headquartered in Montreal, Quebec.
What sector is Hemax Genome in?
Hemax Genome is a life science company.
Life Science M&A Summary in 2005
Out of 60 sectors in the Mergr database, life science ranked 14 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.
Join Mergr to view all 78 acquisitions of life science companies in 2005, including 18 acquisitions by private equity firms, and 60 by strategics.